GlassScriptPhysician profile
David Lee Halsey
NPI 1457319832
$7,594.54
in general payments reported to CMS, 2019-2025
51 companies · $180 in 2025
The $180 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,542 · 2020: $794 · 2021: $1,539 · 2022: $1,796 · 2023: $1,037 · 2024: $707 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,924.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,923.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $729.21 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Amgen INC. | $679.02 | 2019-2025 | Evenity, Prolia, Repatha |
| Astrazeneca Pharmaceuticals LP | $562.20 | 2019-2022 | |
| Novo Nordisk INC | $448.09 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Merck Sharp & Dohme LLC | $396.80 | 2019-2025 | Capvaxive, Vaxneuvance, Pneumovax 23 |
| Abbott Laboratories | $314.50 | 2019-2024 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $309.33 | 2019-2023 | |
| Tandem Diabetes Care, INC. | $278.19 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Corcept Therapeutics | $275.13 | 2019-2025 | Korlym |
| Amarin Pharma, INC. | $261.66 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $252.66 | 2021-2024 | |
| Dexcom, INC. | $250.35 | 2019-2025 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $209.49 | 2019-2023 | Jardiance |
| Radius Health, INC. | $196.20 | 2019-2024 | Tymlos |
| Bayer Healthcare Pharmaceuticals INC. | $188.05 | 2021-2025 |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Halsey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.